Zerumin A is an
anti-angiogenic agent that acts on multiple molecular targets related to angiogenesis (including
kdr/VEGFR2,
angpt1,
angpt2,
tie1, and
tie2). Zerumin A specifically inhibits the proliferation and migration of human umbilical vein endothelial cells (HUVECs) by regulating the VEGF-VEGFR and ANGPT-TIE signaling pathways, and dose-dependently inhibits angiogenesis (10-20 μM significantly inhibits zebrafish embryo angiogenesis). Zerumin A can be used in the research of
cancer and angiogenesis-related inflammatory diseases. Zerumin A can be naturally extracted from the 95% ethanol extract of the fruits, seeds, and pericarp of
Alpinia caerulea (R.Br.) Bentham (a plant of the
Alpinia genus in the
Zingiberaceae family).